How to Overcome Diabetic Retinopathy: Focusing on Blood-Retinal Barrier

Author(s): Dong Hyun Jo, Jin Hyoung Kim, Jeong Hun Kim

Journal Name: Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Under Re-organization)
(Formerly Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents)

Volume 12 , Issue 2 , 2012


Diabetic retinopathy (DR) is one of the common microvascular complications of diabetes, resulting in visual deterioration in working populations. Even in the early stage of DR, increased permeability can occur and is known to be associated with the disruption of the blood-retinal barrier (BRB). In this regard, studies on the pathogenesis of DR have been focused on the alteration of the BRB, however, detailed and unifying mechanisms and pathogenesis-based treatment of DR are yet to be elucidated. In this review, we discussed the pathogenesis of DR associated with the disruption of the BRB and reviewed novel therapeutic options. We expect that this review will help to form a consensus for pathogenesisbased treatments of DR in consideration with the disruption of the BRB.

Keywords: Angiogenesis, blood-retinal barrier, diabetic retinopathy, diabetes, hypoxia, inflammation, oxidative stress, retina, tight Junction, vascular endothelial growth factor

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2012
Page: [110 - 117]
Pages: 8
DOI: 10.2174/187152212800389012
Price: $58

Article Metrics

PDF: 12